Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

EL4 cell-based colorimetric toxin neutralization activity assays for determination of neutralizing anti-ricin antibodies.

Lindsey CY, Brown JE, Torabazar NR, Smith LA.

J AOAC Int. 2013 Jan-Feb;96(1):147-54.

PMID:
23513970
2.

Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

O'Hara JM, Brey RN 3rd, Mantis NJ.

Clin Vaccine Immunol. 2013 Jun;20(6):789-94. doi: 10.1128/CVI.00098-13. Epub 2013 Mar 20.

3.

Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial.

Pittman PR, Reisler RB, Lindsey CY, Güereña F, Rivard R, Clizbe DP, Chambers M, Norris S, Smith LA.

Vaccine. 2015 Dec 16;33(51):7299-306. doi: 10.1016/j.vaccine.2015.10.094. Epub 2015 Nov 3.

PMID:
26546259
4.

Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay.

Porter A, Phillips G, Smith L, Erwin-Cohen R, Tammariello R, Hale M, DaSilva L.

Toxicon. 2011 Jul;58(1):68-75. doi: 10.1016/j.toxicon.2011.05.005. Epub 2011 May 17.

PMID:
21616091
5.

Rapid assessment of antibody-induced ricin neutralization by employing a novel functional cell-based assay.

Gal Y, Alcalay R, Sabo T, Noy-Porat T, Epstein E, Kronman C, Mazor O.

J Immunol Methods. 2015 Sep;424:136-9. doi: 10.1016/j.jim.2015.05.005. Epub 2015 May 21.

PMID:
26003675
6.

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.

Li H, Soroka SD, Taylor TH Jr, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.

J Immunol Methods. 2008 Apr 20;333(1-2):89-106. doi: 10.1016/j.jim.2008.01.007. Epub 2008 Feb 8.

PMID:
18304568
7.

Validation of ELISA for the determination of anti-ricin immunoglobulin G concentration in mouse sera.

Lindsey CY, Pace-Templeton JG, Millard CB, Wannemacher RW, Hewetson JF.

Biologicals. 2006 Mar;34(1):33-41. Epub 2005 Nov 2.

PMID:
16260147
8.

Progress in biological threat agent vaccine development: a repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand white rabbits.

McLain DE, Horn TL, Detrisac CJ, Lindsey CY, Smith LA.

Int J Toxicol. 2011 Mar;30(2):143-52. doi: 10.1177/1091581810396730. Epub 2011 Mar 4.

PMID:
21378370
9.

A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.

Neal LM, O'Hara J, Brey RN 3rd, Mantis NJ.

Infect Immun. 2010 Jan;78(1):552-61. doi: 10.1128/IAI.00796-09. Epub 2009 Oct 26.

10.

Detection of ricin by colorimetric and chemiluminescence ELISA.

Poli MA, Rivera VR, Hewetson JF, Merrill GA.

Toxicon. 1994 Nov;32(11):1371-7.

PMID:
7886695
11.
13.

Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies.

Hu WG, Yin J, Chau D, Hu CC, Lillico D, Yu J, Negrych LM, Cherwonogrodzky JW.

Biomed Res Int. 2013;2013:471346. doi: 10.1155/2013/471346. Epub 2012 Dec 26.

14.

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.

Fournier C, Duverlie G, François C, Schnuriger A, Dedeurwaerder S, Brochot E, Capron D, Wychowski C, Thibault V, Castelain S.

Virol J. 2007 Mar 30;4:35.

15.

Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.

McCutcheon KM, Quarmby V, Song A.

J Immunol Methods. 2010 Jun 30;358(1-2):35-45. doi: 10.1016/j.jim.2010.03.016. Epub 2010 Mar 31.

PMID:
20361968
16.

A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses.

Lehtoranta L, Villberg A, Santanen R, Ziegler T.

J Virol Methods. 2009 Aug;159(2):271-6. doi: 10.1016/j.jviromet.2009.04.015. Epub 2009 May 3.

PMID:
19406159
17.

Characterization and epitope mapping of the polyclonal antibody repertoire elicited by ricin holotoxin-based vaccination.

Cohen O, Mechaly A, Sabo T, Alcalay R, Aloni-Grinstein R, Seliger N, Kronman C, Mazor O.

Clin Vaccine Immunol. 2014 Nov;21(11):1534-40. doi: 10.1128/CVI.00510-14. Epub 2014 Sep 10.

18.

Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.

Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES.

Vaccine. 2005 Sep 15;23(39):4775-84.

PMID:
15961194
19.

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.

Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.

Biologicals. 2010 Nov;38(6):675-83. doi: 10.1016/j.biologicals.2010.09.001. Epub 2010 Sep 28.

PMID:
20875951
20.

Translocation of ricin across polarized human bronchial epithelial cells.

Rushing SR, Saylor ML, Hale ML.

Toxicon. 2009 Aug;54(2):184-91. doi: 10.1016/j.toxicon.2009.04.003. Epub 2009 Apr 15.

PMID:
19374915

Supplemental Content

Support Center